These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2290851)

  • 1. Preclinical anticonvulsant and neuroprotective profile of 8319, a non-competitive NMDA antagonist.
    Fielding S; Wilker JC; Chernack J; Ramirez V; Wilmot CA; Martin LL; Payack JF; Cornfeldt ML; Rudolphi KA; Rush DK
    Prog Clin Biol Res; 1990; 361():533-41. PubMed ID: 2290851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
    Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
    Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
    Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
    Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
    J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, resolution, and SAR of (+/-)-2-amino-N-methyl-alpha-(3-methyl-2-thienyl)benzeneethanamine++ + and related analogs as noncompetitive NMDA antagonists with neuroprotective properties.
    Martin LL; Lee GE; Lee TB; Rush DK; Wilmot CA; Paulus E; Elben U; Grome JJ; Porsche-Wiebking E; Rudolphi KA
    J Med Chem; 1994 Sep; 37(19):3008-15. PubMed ID: 7932522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    Subramaniam S; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
    White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
    J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical anxiolytic profiles of 7189 and 8319, novel non-competitive NMDA antagonists.
    Dunn RW; Corbett R; Martin LL; Payack JF; Laws-Ricker L; Wilmot CA; Rush DK; Cornfeldt ML; Fielding S
    Prog Clin Biol Res; 1990; 361():495-512. PubMed ID: 1981268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA preconditioning protects against seizures and hippocampal neurotoxicity induced by quinolinic acid in mice.
    Boeck CR; Ganzella M; Lottermann A; Vendite D
    Epilepsia; 2004 Jul; 45(7):745-50. PubMed ID: 15230696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
    Montero M; Nielsen M; Rønn LC; Møller A; Noraberg J; Zimmer J
    Brain Res; 2007 Oct; 1177():124-35. PubMed ID: 17894933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticonvulsant effect of phencynonate hydrochloride on maximal electroshock seizure and the metrazol seizure threshold test in mice].
    Wang YA; Zhou WX; Liu YQ; Zheng JQ; Liu KL; Ruan JX
    Yao Xue Xue Bao; 2005 Jun; 40(6):501-6. PubMed ID: 16144313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant activity and interactions with neuronal voltage-dependent sodium channel of analogues of ameltolide.
    Vamecq J; Lambert D; Poupaert JH; Masereel B; Stables JP
    J Med Chem; 1998 Aug; 41(18):3307-13. PubMed ID: 9719582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo treatment with the K+ channel blocker 4-aminopyridine protects against kainate-induced neuronal cell death through activation of NMDA receptors in murine hippocampus.
    Ogita K; Okuda H; Watanabe M; Nagashima R; Sugiyama C; Yoneda Y
    Neuropharmacology; 2005 May; 48(6):810-21. PubMed ID: 15829253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment.
    Ahmed MM; Arif M; Chikuma T; Kato T
    Neurochem Int; 2005 Sep; 47(4):248-59. PubMed ID: 15985312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
    Witkin JM; Gasior M; Heifets B; Tortella FC
    J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.